Marker Therapeutics, Inc.

Daily Archives: Friday, January 4, 2019

Cancer-Focused Marker Therapeutics Shares Rise After Update on Clinical Trial Pipeline

The Houston, Texas-based immuno-oncology group gave an update on five clinical trials.

Read More